Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00915213 · ClinicalTrials.gov registry record
Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy
A clinical trial of Bacterial Infection, sponsored by University of California, Irvine.
- Completed
- Registry status
- 136
- Enrollment target
- 3
- Study locations
NCT00915213 is a study of Bacterial Infection that has completed, run by University of California, Irvine. The registered enrollment target is 136 participants, above the 88-participant average among 8 other Bacterial Infection trials with a reported enrollment target (55% higher). The trial reports 3 study locations across 1 state.
The verdict
NCT00915213, a study of Bacterial Infection, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 136 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to discover how often certain bacteria are found in the rectum at the time of a prostate needle biopsy to diagnose prostate cancer. Certain bacteria are of importance because they can cause serious infection. Antibiotics that urologists commonly use to prevent these bacteria from causing infection are no longer effective. Many physicians around the world are noting increased infections with antibiotic resistant bacteria. Therefore; despite treating patients who are to undergo prostate biopsy with antibiotics, certain patients are being readmitted to the hospital with a serious infection. In order to study the incidence of these particular bacteria, the best method is to culture the bacteria at the time of the biopsy. This involves one rectal culture swab just prior to needle biopsy of the prostate. Once the incidence of these bacteria is known we may take steps to prevent the serious infections that occur as a result of prostate biopsy.
Conditions Studied
Study Locations (3)
California
- Kaiser Permanente - Irvine
- Long Beach Veteran Affairs - Long Beach
- University of California, Irvine Medical Center - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2008-10 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00915213
The ClinicalTrials.gov registry entry for NCT00915213 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 88-participant average among 8 other Bacterial Infection trials with a reported enrollment target (55% higher). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bacterial Infection appearing as the primary indexed condition, and to 0 interventions.
NCT00915213 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00915213 about?
NCT00915213 is a clinical study titled "Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy". The purpose of this study is to discover how often certain bacteria are found in the rectum at the time of a prostate needle biopsy to diagnose prostate cancer. Certain bacteria are of importance because they can cause serious infection. Antibiotics that urologists commonly use to prevent these bact...
What is the current status of trial NCT00915213?
This trial is currently completed. The enrollment target is 136 participants. The study started on 2008-10. Estimated completion is 2014-12.
What conditions does trial NCT00915213 study?
This clinical trial studies the following conditions: Bacterial Infection.
Who is sponsoring clinical trial NCT00915213?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00915213 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)
RECRUITING · Phase 4
-
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
RECRUITING · Phase 4
-
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
COMPLETED · Phase 2
-
Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm
COMPLETED · NA
-
Safety of Intravenous Apramycin in Adults
COMPLETED · Phase 1
-
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.